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Human immunodeficiency virus (HIV)-infected CD8 lymphocytes have been reported in vivo, but the mech-
anism of infection remains unclear. Experiments using the thy/hu mouse model support export of intrathy-
mically infected CD8 precursors, while recent in vitro data suggest that mature CD8 lymphocytes upregulate
CD4 upon activation (generating a CD8bright CD4dim phenotype) and are susceptible to HIV infection. To
determine whether these mechanisms operate in vivo and to assess their relative importance in the generation
of circulating HIV-infected CD8 lymphocytes, we quantified HIV long terminal repeat (LTR) DNA in CD8
CD4 and CD8bright CD4dim lymphocytes isolated from HIV-infected individuals by fluorescence-activated cell
sorting. HIV infection of CD8 lymphocytes was demonstrated in 17 of 19 subjects, with a significant inverse
relationship between level of infection and CD4 lymphocyte count (R  0.73; P < 0.001). The level of HIV
infection of CD8bright CD4dim lymphocytes was significantly higher (median, 1,730 HIV LTR copies/106 cells;
n  9) than that of CD8 CD4 lymphocytes (undetectable in seven of nine individuals; P < 0.01) and
approached that of CD4 lymphocytes from the same individuals (median, 3,660 HIV LTR copies/106 cells).
CD8bright CD4dim lymphocytes represented 0.8 to 3.3% of total CD8 lymphocytes and were most prevalent in
the memory subset. Thus, HIV-infected CD8 lymphocytes commonly circulate in HIV-infected individuals and
are generated through infection of activated CD8 lymphocytes rather than through export of intrathymically
infected precursors. The high level of infection of CD8bright CD4dim lymphocytes could have a direct role in the
decline in CD8 lymphocyte function that accompanies HIV disease progression.
Although the major cellular target of human immunodefi-
ciency virus type 1 (HIV-1) is the CD4 lymphocyte, there is
increasing in vitro (8, 17, 33, 35, 36) and in vivo (3, 8, 14, 20, 21,
29, 30) evidence that CD8 lymphocytes are also susceptible to
HIV-1 infection. It is well established that in chronic HIV
infection, deterioration in CD8 lymphocyte function accompa-
nies progression to symptomatic disease (12, 19, 24). While this
is generally ascribed to lack of CD4 lymphocyte help or to
soluble viral factors, it is also possible that direct infection of
CD8 lymphocytes by HIV may contribute to their functional
decline. In addition to the potential immunosuppressive effect,
infection of CD8 lymphocytes generates a reservoir of circu-
lating HIV-infected cells, with implications for virus dissemi-
nation and antiviral escape (25).
Various mechanisms for HIV entry into CD8 lymphocytes
have been proposed, including cell-to-cell transfer (5), selec-
tion of CD8-tropic HIV variants (34, 35), or entry through a
conventional CD4-dependent pathway. Two opportunities for
CD4-dependent HIV entry into CD8 lymphocytes have been
identified. The first occurs during intrathymic CD8 lymphocyte
development and the second upon activation of the mature
CD8 lymphocyte. Intrathymic CD8 lymphocyte precursors ex-
press CD4 and are susceptible to HIV infection in vitro (7). In
the thy/hu mouse model, maturation and export of HIV-in-
fected lymphocyte precursors have been shown to generate cir-
culating HIV-infected naïve lymphocytes (4). Such cells could
survive in a resting state for years, acting as a reservoir of
provirus unaffected by antiretroviral agents.
A number of investigators have shown that activation of
mature CD8 lymphocytes in vitro leads to CD4 expression on
the cell surface (8, 17, 31), and this mechanism is thought to
generate the circulating CD8bright CD4dim lymphocytes ob-
served in vivo (14). HIV infection of in vitro-activated CD8
lymphocytes has been demonstrated (8, 17, 35, 36). Infection of
CD8 lymphocytes by this mechanism would target infection to
cells responding to antigens, and thus, infection of a relatively
small number of cells could have a disproportionately high
impact on immune function.
To determine the relative importance of these different
mechanisms of infection in the generation of circulating HIV-
infected CD8 lymphocytes in vivo, we used PCR to quantify
HIV long terminal repeat (LTR) DNA in CD8 lymphocyte
subsets sorted on the basis of differentiation phenotype or CD4
expression. This method detects HIV provirus and HIV pre-
integration complexes, with each HIV DNA genome contain-
ing 2 LTR copies. It provides a measure of the level of HIV
infection within a given cell population. Differentiation phe-
notype was defined in terms of CD45RA and CD27 expression,
allowing cells to be divided into antigen-naïve, memory, and
effector subsets. Intrathymic infection would be expected to
generate HIV-infected naïve CD8 lymphocytes with no pref-
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erence for CD8 lymphocytes expressing CD4. In contrast, in-
fection during activation would be expected to generate HIV-
infected, antigen-experienced CD8 lymphocytes, with higher
levels of infection in CD8 lymphocytes expressing CD4.
We also used four-color flow cytometry to investigate the
differentiation phenotype of CD4-expressing CD8 lymphocytes
isolated from HIV-infected subjects. CD8 lymphocytes in-
duced to express CD4 in vitro have been shown to have cyto-
kine expression profiles in keeping with a significant role in
immune function (18, 36), but little is known about the rela-
tionship between CD4 expression and progression from naïve
to memory or effector status in vivo.
MATERIALS AND METHODS
Subjects. Twenty 30- to 50-ml blood samples were drawn from 19 HIV-
infected individuals attending health care services in Scotland (Table 1). Because
each sample contained insufficient CD8 lymphocytes to assess HIV infection of
all the cell subsets of interest, the samples were divided into two groups. CD8
lymphocytes in the first group were sorted on the basis of CD4 expression (n 
9), and those in the second were sorted on the basis of differentiation phenotype
(n  11). Subjects were selected in such a way as to ensure a range of disease
stages, from asymptomatic to advanced AIDS, in each group. Three individuals
were long-term nonprogressors (defined as persons who had maintained a CD4
count above 300 without antiretroviral therapy despite more than 10 years of
infection), and 13 were receiving combination antiretroviral therapy at the time
of sampling. The mean age of the subjects was 39 (range, 29 to 54).
Isolation of lymphocyte populations. Each blood sample was taken into tubes
containing EDTA. Peripheral blood mononuclear cells (PBMCs) were obtained
by density centrifugation over Histopaque (Sigma Diagnostics, St. Louis, Mo.)
and washed twice in phosphate-buffered saline (Invitrogen, Paisley, United King-
dom), and lymphocyte subsets were isolated. In order to achieve very high cell
population purity, the populations of interest were first enriched by using im-
munomagnetic technology and then isolated by fluorescence-activated cell sort-
ing (FACS). This two-stage process was performed for all subjects except subject
10, for whom cell sorting was performed directly on PBMCs.
Where CD8 lymphocytes were to be separated by differentiation phenotype,
cell populations were enriched by the following steps: (i)  T lymphocytes were
removed by negative selection using a magnetic cell sorting (MACS)  T-
lymphocyte isolation kit (Miltenyi Biotec Ltd. [UK], Bisley, United Kingdom);
(ii) from the  T-lymphocyte-negative population, CD8 lymphocytes were en-
riched by using MACS CD8 microbeads (Miltenyi Biotec); (iii) from the CD8-
negative population, CD4 lymphocytes were enriched by using MACS CD4
microbeads (Miltenyi Biotec). Where CD8 lymphocytes were to be separated
into populations on the basis of CD4 expression, steps ii and iii of this protocol
were used.
Enriched populations were incubated for 30 min at 4°C with appropriate
fluorescent dye-conjugated monoclonal antibodies (Table 2). Cells were then
fixed in 0.75% paraformaldehyde (Sigma Diagnostics) at 4°C for 1 h, after which
they were resuspended in phosphate-buffered saline and stored for a maximum
of 4 days prior to flow sorting. High-purity CD4 lymphocytes and CD8 lympho-
cyte subpopulations were then isolated by using a FACSVantage (Becton Dick-
inson, Crawley, United Kingdom) flow sorter (Fig. 1). To ensure that the sorted
CD8 lymphocytes were not contaminated by minor populations of other cell
types expressing CD8 (such as CD4 lymphocytes and NK cells), the anti CD8
monoclonal antibody used was directed against the  chain of the CD8 molecule,
which has been shown to define true CD8 lymphocytes (13). In sorting of the
CD8bright CD4dim population, a tight lymphocyte gate and a low flow rate (ap-
proximately 2,000 events/s) were used in order to avoid cell aggregates and to
minimize coincidence error.
Nucleic acid extraction and HIV DNA quantification. DNA was isolated from
the cell subsets by phenol-chloroform extraction and ethanol precipitation, and
the DNA concentration was measured by using a GeneQuant II spectrophotom-
eter (Amersham Biosciences, Cambridge, United Kingdom). Real-time PCR was
used to quantify HIV LTR DNA copies per microgram of DNA, and the copy
number was then confirmed at limiting dilution. The real-time PCR was per-
formed using a nested approach with a conventional primary reaction and a
real-time secondary reaction. The primary reaction used primers GRAACC
CACTGCTTAASSCTCAA (sense) and AAGCCGAGYCCTGCGTCGAGAG
(antisense) (5 base positions 506 and 686 of the HXB2 genome) with an an-
nealing temperature of 55°C and ran for 18 cycles. The secondary reaction used
primers CTCAATAAAGCTTGCCTTGAG (sense) and TGTTCGGGCGCCA
CTGCTAGAGA (antisense) (5 base positions 524 and 626 of the HXB2 ge-
TABLE 1. Clinical profiles of HIV-infected subjectsa
Study
subjectb
CD4
count/l
Plasma viral
load/ml
Combination
antiretroviral therapyc
1 2 75,000 No
2 17 750,000 Yes
3 39 309 Yes
4 51 23,100 No
5 66 75,000 Yes
6 117 75,000 Yes
7 123 330,000 Yes
8 296 470 Yes
9 328 50 Yes
10 334 50 No
11 339 14,900 Yes
12 364 304 No
13 385 153 Yes
14 393 403 Yes
15 396 862 No
16 509 50 Yes
17 531 50 Yes
18 647 13,400 No
19A 824 1,900 Yes
19B 887 50 Yes
a Ranked by CD4 count (from low to high).
b Identification numbers of long-term nonprogressors are italicized. Blood
samples were drawn from subject 19 on two occasions.
c Yes, subject was prescribed at least three antiretroviral agents at the time
when the sample was drawn.
TABLE 2. Monoclonal antibodies used to stain cell populations for FACS and flow cytometry
Cell population stained
Fluorescent dye-conjugated
mouse anti-human mono-
clonal antibodya
Clone Company
CD8 lymphocytes to be separated by differentiation phenotype
and PBMCs for assessment of differentiation phenotype of
CD8 lymphocytes expressing CD4
CD27 FITC M-T271 BD Biosciences
CD8 chain PE 2ST8.5H7 Coulter Immunotech
CD45RA Cy-chrome HI100 Pharmingen
CD4-APC RPA-T4 BD Biosciences
CD8 lymphocytes to be separated by CD4 expression CD8 chain PE 2ST8.5H7 Coulter Immunotech
CD4 Cy-chrome RPA-T4 BD Biosciences
CD4 lymphocytes CD3 PE UCHT1 BD Biosciences
CD4 Cy-chrome RPA-T4 BD Biosciences
a FITC, fluorescein isothiocyanate isomer 1; PE, phycoerythrin; APC, allophycocyanin.
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nome) (obtained from Oswell, Southampton, United Kingdom) and hybridiza-
tion probes LCRed705-ACTCTGGTARCTAGAGATCCCTCAGA-phosphate
and AAGTAGTGTGTGCCCGTCTGTTGT-fluorescein (Tib Molbiol, Berlin,
Germany) and was performed on a Light Cycler (Roche, Mannheim, Germany)
annealing at 55°C, with external standards. This method was sensitive to a single
copy, as assessed against National Institute for Biological Standards and Control
(NIBSC) HIV-1 DNA standards (provided by the European Union Programme
EVA/MRC Centralised Facility for AIDS Reagents, NIBSC, Potters Bar, Hert-
fordshire, United Kingdom [grants QLK2-CT-1999-00609 and GP828102]; do-
nated by J. Bootman), and was validated against serial dilutions of cloned
full-length HIV-1.
Limiting-dilution PCR was then performed to confirm the estimated LTR
copy number by using published Pan-LTR primers and thermocycling conditions
(14). Ten replicate reactions were performed at the DNA concentration ex-
pected to contain 0.5 copy per reaction. Further dilutions were performed if
necessary to produce replicates containing both positive and negative results.
HIV DNA load and standard error were then estimated by using the QUALITY
program (27) and were expressed as LTR DNA copies per 106 cells, assuming 6.6
g of DNA per 106 cells. For samples where only a single positive replicate was
generated due to limited availability of viral DNA, no standard error is provided.
The correlation between the original real-time PCR estimate and the final result
provided by limiting dilution was 0.79 (P 0.001) (Spearman’s rank correlation).
This DNA extraction and LTR quantification protocol was found to have high
reproducibility when tested on five replicate samples of paraformaldehyde-fixed
PBMCs from an HIV-infected subject (mean, 60 LTR DNA copies/106 cells;
range, 26 to 100).
Purity of cell subsets and calculation of attributable HIV DNA loads. The level
of CD4 lymphocyte contamination of CD8 lymphocyte subsets (defined as the
percentage of cells that were CD4 CD8	) was assessed by flow cytometry and
was found to be low (mean, 0.05% [Tables 3 and 4]). For subsets with adequate
cell numbers (naïve and experienced CD8 lymphocytes and CD8 CD4	 lym-
phocytes), at least 1,000 (mean, 4,880) ungated events were assessed. Within
subjects, the purity of memory and effector populations was taken to be equiv-
alent to that of antigen-experienced populations. For populations of rare cells
FIG. 1. FACS of CD4 lymphocytes and CD8 lymphocyte subsets. (A) CD8 lymphocytes sorted on the basis of CD4 expression; (B and C) CD8
lymphocytes sorted on the basis of differentiation phenotype; (D) CD4 lymphocytes. Sorting on the basis of differentiation phenotype was
performed in two stages: first, enriched CD8 lymphocytes were sorted into antigen-naïve and antigen experienced subsets (B); then a portion of
the antigen-experienced subset was retained for HIV DNA analysis, and the remainder was further sorted into memory and effector subtypes (C).
FSC, forward scatter; SSC, side scatter.
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(CD8bright CD4dim), sufficient cells were available to assess purity in four sub-
jects. At least 500 (mean, 860) events were assessed, and due to the high ratio of
background to cellular events, events falling outside the lymphocyte gate (de-
fined on light scatter properties) were excluded. Where purity was not measured
directly, the purity of CD8bright CD4dim lymphocytes was taken to be equivalent
to that of CD8 CD4	 lymphocytes. Where no purity data were available
(subjects 9 and 17), a level of 0.2%, which represents the 75th percentile of the
available CD4 contamination data, was used. Microscopic examination of sorted
CD8bright CD4dim lymphocytes from one subject confirmed that they represented
a single cell suspension free from aggregates.
For each CD8 lymphocyte subset, the HIV DNA load attributable to CD4
lymphocyte contamination was calculated from the cell population purity data
and the CD4 lymphocyte HIV DNA load. This figure was then subtracted from
the observed HIV DNA load in the CD8 lymphocyte subset to give the HIV
DNA load attributable to CD8 lymphocytes. Where CD8 lymphocytes were
found to be infected, the HIV DNA load observed in the CD8 lymphocyte subset
was 
5 times that attributable to CD4 contamination in all but three cases. All
HIV DNA loads given in Results for CD8 lymphocyte subsets are attributable to
the CD8 lymphocytes.
Distribution of CD8 lymphocytes expressing CD4. The differentiation pheno-
type, in terms of CD45RA and CD27 expression (Fig. 1), of CD8 lymphocytes
expressing CD4 was assessed for 13 subjects by using a FACScalibur flow cy-
tometer (Becton Dickinson). For seven subjects this assessment was performed
on sorted naïve and experienced CD8 lymphocyte populations, while for the
remainder appropriately stained PBMCs were used (Table 2). Populations were
gated according to the differentiation phenotypes given (Fig. 1), and the per-
centage of CD8 lymphocytes expressing CD4 in each population was determined.
A tight lymphocyte gate was used to exclude cell aggregates.
RESULTS
Extent of HIV infection of CD8 lymphocytes. To assess the
level of HIV infection of CD8 lymphocytes in subjects with a
range of disease stages, HIV LTR copies were quantified in
CD8 lymphocytes isolated from HIV-infected subjects. HIV
infection of CD8 lymphocytes was demonstrated in 17 out of
19 subjects. The level of infection was low (median, 16 HIV
LTR DNA copies per 106 CD8 lymphocytes; range, undetect-
able to 436 [Fig. 2A]), significantly lower than that of CD4
lymphocytes from the same subjects (median, 3,660 LTR DNA
copies/106 cells; range, 16 to 25,512 [P 0.001 by the Wilcoxon
signed rank test] [Fig. 2A]). The possibility that the viral DNA
found within the CD8 lymphocyte subsets represented contam-
ination from CD4 lymphocytes was excluded by determining
the purity of the CD8 lymphocyte populations and calculating
attributable HIV DNA loads (see Materials and Methods). No
significant correlation was found between HIV DNA loads in
CD4 and CD8 lymphocytes (Spearman’s correlation coeffi-
cient, 0.3; P 
 0.1).
There was an inverse correlation between CD4 lymphocyte
counts and CD8 lymphocyte HIV DNA loads (Spearman’s
correlation coefficient [R], 	0.73; P  0.001 [Fig. 3A]), indi-
cating a progressive increase in the prevalence of infected CD8
lymphocytes with advancing disease. In individuals with ad-
vanced disease, the higher prevalence of infected CD8 lym-
phocytes, together with dwindling CD4 lymphocyte numbers,
increased the contribution of CD8 lymphocytes to the total
circulating HIV DNA load. Thus, for the individuals with the
lowest CD4 lymphocyte counts, CD8 lymphocytes contributed
more than 25% of the total HIV DNA load in circulating
lymphocytes (Fig. 3B). In contrast, the CD8 lymphocytes of
long-term nonprogressors appear relatively resistant to infec-
tion, with virtually no LTR copies detected.
Phenotype of HIV-infected CD8 lymphocytes. In order to
determine the relative contributions of intrathymic infection
versus infection of activated cells in the generation of circulat-
ing HIV-infected CD8 lymphocytes, HIV LTR DNA was
quantified in subsets of CD8 lymphocytes. For the first nine
subjects, CD8 lymphocyte subsets were divided on the basis of
CD4 expression (Fig. 2B). CD8 lymphocytes expressing CD4
(CD8bright CD4dim) were found to be infected in seven out of
nine subjects (78%) with relatively high levels of infection
(median, 1,730 LTR DNA copies/106 cells; range, undetectable
to 7,902), approaching those in the CD4 lymphocytes of the
same nine subjects (Fig. 4A). In contrast, only two of nine
subjects (22%) showed infection of CD8 CD4	 lympho-
cytes, and this was at low levels (10 and 4 LTR DNA copies/106
cells). The increase in HIV DNA load in CD8bright CD4dim
lymphocytes compared to that in CD8 CD4	 lymphocytes
was significant (P  0.01 where undetectable values were as-
signed a value half the lower limit of detection, and P  0.05
where undetectable values were assigned a value of zero, by
the Wilcoxon signed rank test).
For the remaining 11 subjects, levels of HIV infection were
compared in CD8 lymphocyte subsets divided on the basis of
differentiation phenotype (Fig. 2C and 4B). Infection levels
TABLE 3. Levels of CD4 lymphocyte contamination of
CD8 CD4	 and CD8bright CD4dim lymphocytes
Study subject
% CD4 lymphocyte contaminationa of:
CD8 CD4	
lymphocytes
CD8bright CD4dim
lymphocytes
1 5  10	3 NA
5 9  10	4 NA
6 0.1 0.56
7 0.01 NA
11 0.17 0.20
13 0.01 NA
14 0.13 2.44
15 0.3 NA
19B 0.11 0.74
Median 0.1 0.65
a NA, not available.
TABLE 4. Levels of CD4 lymphocyte contamination of naı¨ve
and antigen-experienced CD8 lymphocytes
Study subject
% CD4 lymphocyte contaminationa of:
Naı¨ve CD8
lymphocytes
Antigen-experienced
CD8 lymphocytes
2 0.2 0.01
3 0.03 NA
4 0.03 0.1
8 0.03 0.03
9 NA NA
10 0.41b NA
12 0.05 0.05
16 0.04 0.03
17 NA NA
18 0.1 0.79
19A 0.02 0.04
Median 0.04 0.03
a NA, not available.
b PBMCs from subject 10 were not enriched prior to FACS.
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were generally quite low (range, 3 to 274 LTR DNA copies/
106 cells), and although HIV DNA was more frequently de-
tected in antigen-experienced than in antigen-naïve popula-
tions, there was no significant difference in HIV DNA loads (P
 0.7 by the Wilcoxon signed rank test). Further subdivision of
the antigen-experienced cells into memory and effector subsets
was performed for four of the subjects with detectable HIV
DNA. Of these, three demonstrated infection in the memory
subset and one demonstrated infection in the effector subset
(Fig. 2C), again with no significant difference in viral DNA loads.
Prevalence and differentiation status of CD8 lymphocytes
expressing CD4. In order to investigate the relationship be-
tween CD8 lymphocyte differentiation and CD4 expression in
vivo, we used four-color flow cytometry to assess CD4, CD8,
CD45RA, and CD27 expression in 13 HIV-infected subjects.
Distinct CD8bright CD4dim populations were detected in all
study subjects, and the density of CD4 expression on CD8bright
CD4dim lymphocytes was approximately half (mean, 0.4; range,
0.3 to 0.6) that on true CD4 lymphocytes. The proportion of
CD8 lymphocytes found to express CD4 was between 0.8 and
3.3% and was not found to correlate with CD4 or CD8 lym-
phocyte counts.
In keeping with the hypothesis of CD4 expression following
activation, the vast majority of CD8bright CD4dim lympho-
cytes had an antigen-experienced phenotype (mean, 92%;
range, 47 to 99%). Interestingly, most of the antigen-experi-
enced CD8bright CD4dim lymphocytes displayed a memory
(mean, 75%; range, 47 to 96%) as opposed to an effector
(mean, 12%; range, 0 to 31%) phenotype. This preponderance
of antigen-experienced and memory phenotypes is not simply a
reflection of the distribution of phenotypes in the total CD8
lymphocyte population, because the proportion of CD8 lym-
phocytes expressing CD4 was significantly greater in the anti-
gen-experienced population than in the antigen-naïve popula-
tion (P  0.05 by paired t test) and significantly greater in the
memory subset than in the effector subset (P  0.01 by paired
t test [Fig. 5]).
The differentiation phenotype of CD8bright CD4dim lympho-
cytes was also assessed in three healthy volunteers. All three
demonstrated a differentiation pattern similar to that observed
in the majority of HIV-infected subjects, with the greatest pro-
portion of CD8 lymphocytes expressing CD4 observed in the
memory subset (range, 3.8 to 6.3%) and markedly less found in
the effector (range, 1.0 to 2.0%) and naïve (range, 1.1 to 2.8%)
subsets.
DISCUSSION
This study confirms that CD8 lymphocytes are infected with
HIV in vivo and demonstrates that CD8 lymphocytes express-
ing CD4 have a high frequency of infection. It is the first study
FIG. 2. Levels of HIV infection in CD4 lymphocytes and CD8 lymphocyte subsets. (A) CD4 and CD8 lymphocytes; (B) CD8bright CD4dim and
CD8 CD4	 lymphocytes; (C) CD8 lymphocytes divided by differentiation phenotype. Solid diamonds, attributable HIV DNA load. Shaded
diamonds, samples where no virus was detected; the value given is half the lower limit of detection, which varies with the number of cells available
for analysis. P values shown were calculated using the Wilcoxon signed rank test.
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to correct the level of infection of CD8 lymphocytes for directly
measured CD4 lymphocyte contamination and therefore rep-
resents a methodological advance over previous studies (14,
21). The high infection levels found in CD8bright CD4dim lym-
phocytes support the hypothesis that infection of this subset
could have a direct role in the AIDS-related decline in CD8
lymphocyte function.
Route of CD8 lymphocyte infection. CD4-dependent HIV
infection of CD8 lymphocytes has been demonstrated during
intrathymic development (4, 7) and following activation of
mature lymphocytes (8, 14, 17, 35). Given that CD8 lympho-
cyte precursors would be expected to lose CD4 before leaving
the thymus, our observation of very low or undetectable viral
DNA loads in CD8 CD4	 lymphocytes implies that this
FIG. 3. Increased HIV infection of CD8 lymphocytes with disease progression. (A) Correlation between CD8 lymphocyte HIV DNA load and
CD4 count (Spearman’s rank correlation coefficient [R]). Cases with undetectable proviral loads were given a value of half the lower limit of
detection. (B) Relative contributions of CD4 and CD8 lymphocytes to overall circulating HIV DNA loads were calculated from CD4 and CD8
lymphocyte HIV DNA loads and from CD4 and CD8 lymphocyte counts. Undetectable viral loads were given a value of zero.
FIG. 4. HIV DNA loads for each subject. HIV DNA loads for CD4 lymphocytes and CD8 lymphocyte subsets for each subject (ordered by
ascending CD4 lymphocyte count) are given. (A) CD8 lymphocytes were divided on the basis of CD4 expression; (B) CD8 lymphocytes were
divided by differentiation phenotype. Error bars indicate standard errors (see Materials and Methods); they are absent from samples where
insufficient cells were available. Stars indicate samples where no virus was detected; the value given is half the lower limit of detection.
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route is contributing little to the circulating HIV-infected CD8
lymphocytes. In contrast, the higher viral DNA levels observed
in the CD8bright CD4dim population suggests frequent infection
of this subset of mature CD8 lymphocytes. This distribution of
HIV DNA is in keeping with previous results from our group
in which CD8 CD4 cells isolated by immunomagnetic meth-
ods were found to contribute a higher proportion to the overall
proviral load than their CD4-negative counterparts (14). Sim-
ilarly, in a recent paper, Brenchley et al. observed that there
are 5- to 100-fold more HIV gag DNA copies in CD8 CD4dull
lymphocytes than in CD8 lymphocytes lacking CD4 expression
(3).
The distribution of HIV DNA between CD8 lymphocytes at
sequential stages of differentiation can also provide informa-
tion regarding the likely route of infection. The use of pheno-
typic markers to define differentiation stages of CD8 lym-
phocytes has been a topic of much debate (11). CD27 and
CD45RA have been demonstrated to define populations
with distinct cytokine profiles, and a differentiation pathway
from CD27 CD45RA (antigen naïve) to CD27 CD45RA	
(memory) and then to CD27	 CD45RA (effector) has been
proposed (9, 10, 15). Further experiments indicated that

90% of CD27 CD45RA CD8 lymphocytes were “true
naïve” as defined by a panel of three further phenotypic
markers (6), though early antigen-experienced cells may retain
the CD27high CD45RA (naïve) phenotype (1). The relation-
ship between differentiation markers and memory versus ef-
fector function remains unclear (1), and we therefore recog-
nize that while we retain the labels “memory” and “effector”
for the CD27 CD45RA	 and CD27	 CD45RA subsets,
respectively, a degree of functional overlap is likely.
Given the observed distribution of HIV DNA in CD8bright
CD4dim versus CD8 CD4	 lymphocytes, and the evidence
that CD4 upregulation on CD8 lymphocytes follows antigen
recognition (8, 17, 31), one would expect HIV DNA levels to
be relatively high in antigen-experienced CD8 lymphocytes but
very low in the antigen-naïve subset. Interestingly, although
HIV DNA was more frequently detected in the antigen-expe-
rienced populations, it was also demonstrated in the naïve
subset for 4 out of 11 subjects. These HIV-infected naïve CD8
lymphocytes are likely to be cells early in the activation process
that have upregulated CD4 but have not yet lost their naïve
markers. This interpretation is supported by our finding of
CD4 expression on lymphocytes with the CD45RA CD27high
(naïve) phenotype (Fig. 5) and suggests that, at least in some
subjects, HIV infection of CD8 lymphocytes is occurring very
early in the activation process. Recently published data showed
negligible HIV DNA levels in naïve CD8 lymphocyte popula-
tions from which cells expressing CD4 had been removed (3),
supporting our suggestion that CD4-expressing cells are re-
FIG. 5. Phenotype of CD8bright CD4dim lymphocytes. (A) The differentiation phenotype of CD8bright CD4dim lymphocytes was assessed in
terms of CD45RA and CD27 expression. Dot plots from PBMCs of a representative subject (subject 10) are shown comparing the distribution of
all CD8 lymphocytes (i) against that of CD8bright CD4dim lymphocytes (ii). The lack of expression of CD4 on the CD45RA CD27	 (effector)
subset is clearly seen. (B) Percentages of CD8 lymphocytes found to express CD4 in antigen-naïve, antigen-experienced, memory, and effector
subsets are shown for 13 subjects. Circles, outliers; stars, extreme outliers. P values were calculated by using the paired t test.
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sponsible for the HIV observed in our naïve CD8 lymphocyte
populations. Alternatively, the HIV DNA observed in our naïve
cell populations may originate in contaminating nonnaïve cells
which were excluded in the Brenchley et al. experiment
through use of a more stringent definition of naïve cells (3).
The lack of correlation between the level of infection in CD4
and CD8 lymphocytes suggests that, although we propose that
HIV enters both cells via the CD4 receptor, different factors
influence the frequency of this event in the two cell types. The
observation of a clear inverse correlation between CD8 lym-
phocyte HIV DNA load and CD4 count indicates that disease
progression may be one factor that favors CD8 lymphocyte in-
fection. Teasing out the relative importance of the many other
host, viral, and therapeutic factors that are likely to influence
CD8 lymphocyte infection would be of major value in future
studies.
Phenotype of CD8bright CD4dim lymphocytes. Given the find-
ing that CD8bright CD4dim lymphocytes are a major target for
HIV infection, a clear understanding of the natural history of
these cells in HIV-infected subjects is a priority. In vitro, CD4
is markedly upregulated upon costimulation of naïve CD8 lym-
phocytes, with CD4 expression accompanying the appearance
of activation markers and a change from a naïve to an antigen-
experienced phenotype (17, 31). Our observation that the ma-
jority of CD8bright CD4dim lymphocytes circulating in vivo have
an antigen-experienced phenotype is in keeping with this in
vitro finding. CD4 expression was also observed in a small
proportion of naïve CD8 lymphocytes, and, as discussed ear-
lier, it is likely that these were recently activated, suggesting
that CD4 expression is an early event in the activation process.
Within the antigen-experienced population, CD4 was ex-
pressed in a much higher proportion of CD27 CD45RA	
(memory) than terminally differentiated CD27	 CD45RA
(effector) CD8 lymphocytes. In the context of the proposed
linear pathway of CD8 lymphocyte differentiation from naïve
to memory and then to effector function (9, 10), these findings
suggest that memory CD8 lymphocytes expressing CD4 either
fail to differentiate to effector status or downregulate CD4
expression prior to further differentiation. Failure to differen-
tiate could reflect deletion of CD4-expressing cells through
HIV infection; however, the decreased frequency of CD4 ex-
pression in effector cells was also observed in three healthy
volunteers, suggesting that non-HIV-related mechanisms are
involved.
In 2 out of the 13 subjects assessed, an unusually high pro-
portion of effector CD8 lymphocytes was found to express CD4
(indicated as outliers in Fig. 5B). These subjects had the high-
est overall proportion of CD8bright CD4dim lymphocytes (
4%
of all CD8 lymphocytes), and, in contrast to the remaining 11
subjects, the proportion in the effector population was greater
than that in the memory population. It is possible that the high
levels of CD8bright CD4dim lymphocytes in these subjects re-
flected acute responses to intercurrent infection (23), and one
of the subjects had clinical diagnoses of pneumonia and otitis
media at the time of sampling.
Taken together, the HIV DNA load and the CD4 expression
data allow us to put forward a model for the route of HIV
infection of circulating CD8 lymphocytes (Fig. 6). We propose
that export of HIV-infected CD8 lymphocyte precursors from
the thymus occurs rarely if at all and that the vast majority of
infected CD8 lymphocytes acquire HIV through expression of
CD4 during activation. CD4 expression can be induced early in
FIG. 6. Proposed infection route of CD8 lymphocytes circulating in vivo. We propose that circulating HIV-infected CD8 lymphocytes are
generated through CD4-mediated infection of activated CD8 lymphocytes and that export of HIV-infected CD8 precursors from the thymus occurs
rarely if at all. Since only a minority of memory CD8 lymphocytes express CD4, we propose that expression is transient and therefore show a
CD4-negative “later ” memory CD8 lymphocyte. It is also possible that CD4 is expressed on a stable minority of memory CD8 lymphocytes. Dotted
arrows represent possible lineage associations between cell types.
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the activation of naïve cells, and HIV infection can be rapid, in
some cases occurring before the loss of naïve markers. The
relationship between effector CD8 lymphocytes and both CD4
expression and HIV infection is interesting. Although we iso-
lated effector cells from only four subjects, we have shown that
in general, effector cells do not express CD4, and CD4-nega-
tive cells are rarely HIV infected. From this we can infer that
effector cells are infrequent carriers of HIV. This suggests
either that HIV infection of CD8 lymphocytes blocks progres-
sion to effector status (through, for example, cell death or
interference with differentiation signals) or that CD4 expres-
sion occurs only on a subset of activated CD8 lymphocytes
which have a different differentiation pathway. The picture is
complicated by the two subjects with high levels of CD4 ex-
pression on effector lymphocytes and the one subject whose
isolated effector CD8 lymphocytes were found to carry HIV
DNA. Clearly, the dynamics of CD4 expression and HIV in-
fection of this important subset of CD8 lymphocytes is an area
where further study is a priority.
Impact of HIV infection of CD8bright CD4dim lymphocytes.
The importance of CD8 lymphocytes in the control of HIV
replication and the decline in CD8 lymphocyte function with
progression to AIDS have been clearly demonstrated (16, 22,
32). The decline in CD8 lymphocyte function is commonly
ascribed to lack of CD4 lymphocyte help and viral escape
(reviewed in reference 22), but our group and others (8, 14, 17,
20, 21, 30, 35) have proposed that, in addition to the mecha-
nisms referred to above, infection of CD8 lymphocytes with
HIV may directly compromise CD8 lymphocyte function. The
present finding of HIV infection in CD8bright CD4dim lympho-
cytes demonstrates targeted infection of cells responding to
antigen. This process could clearly have a significant effect on
the immune control of both HIV and opportunistic pathogens
and may contribute to the observed correlation between im-
mune activation and poor outcome (2).
Implications for therapeutic advances. As the limitations of
current antiviral therapies have become apparent, there has
been increasing interest in therapeutic immune activation as a
mechanism for achieving improved viral control. Strategies in-
clude the use of immune stimulants in conjunction with anti-
retroviral agents (26) and structured treatment interruptions
where antiviral therapy is stopped to allow HIV to replicate
and thus stimulate an anti-HIV immune response (28). In the
light of our findings, it is clear that such therapies should be
developed with caution, with evaluation of their effect on in-
fection of CD8 lymphocytes. Structured treatment interrup-
tions should be viewed as particularly hazardous, because they
allow immune activation in the presence of actively replicating
HIV.
In conclusion, we have shown that CD8 lymphocytes ex-
pressing CD4 contain high levels of HIV DNA in vivo, while
CD8 lymphocytes lacking CD4 expression have low or unde-
tectable levels. This finding supports the infection of activated
mature CD8 lymphocytes over infection of thymic precursors
as the major mechanism responsible for the generation of
circulating HIV-infected CD8 lymphocytes. In the future it will
be important to investigate factors influencing the expression
of CD4 on CD8 lymphocytes and to formally assess the impact
of infection of these cells on HIV immunopathogenesis.
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